Effects of n-3 Polyunsaturated Fatty Acids and Antioxidants on Postprandial Hyperlipidemia and Vascular Function in Men

Last updated: September 21, 2015
Sponsor: Laval University
Overall Status: Completed

Phase

2/3

Condition

Low Blood Pressure (Hypotension)

Vascular Diseases

Treatment

N/A

Clinical Study ID

NCT00296595
MOP-64438
  • Ages 18-70
  • Male
  • Accepts Healthy Volunteers

Study Summary

Diet has long been used as a way to provide enough nutrients to an individual in order to meet metabolic requirements. However, recent scientific advancements have suggested that beyond meeting nutrition needs, diet may also be health promoting through the modulation of various body functions. In a way, the role of nutrition has evolved from hunger satisfaction and maintenance of body integrity to the promotion of a state of well-being and prevention of important chronic diseases such as cancer, diabetes and cardiovascular disease (CVD). In recent years, n-3 polyunsaturated fatty acids (PUFA) have attracted much attention as consumption of a n-3 PUFA rich diet has been reported to reduce CVD risk. However, n-3 PUFA are also highly susceptible to free radical damage and therefore could be unable to fully exert their health benefits under an oxidative stress condition. The general objective of the present application is to investigate the mechanisms by which n-3 PUFA improve cardiovascular health in abdominal obesity and explore the potential of dietary antioxidants to modulate these effects in individuals at high risk of oxidative stress. For that purpose, we plan to study the changes in fasting and postprandial plasma lipoprotein-lipid levels, markers of lipid and lipoprotein oxidation, inflammation and endothelial dysfunction following 12 weeks of n-3 PUFA supplementation with or without low-calorie cranberry juice cocktail (as a source of antioxidants) in a group of 160 men. We feel that the present study will broaden our understanding of the physiological mechanisms underlying the beneficial effects of consuming unsaturated fatty acids and give further insights on the role of antioxidants in preserving and potentiating these cardiovascular health benefits.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Waist circumference > 90 cm

  • Fasting triglycerides > 1.7 mmol/L

  • No use (ever) of medications for the treatment for dyslipidemia or hypertension

Exclusion

Exclusion Criteria:

  • Alcohol consumption > 1 drink per day i.e ~15 g of alcohol/day or the equivalent of 1beer (12 oz or 341 mL), 1 glass of wine (4 oz or 125 mL) or 1 ounce (30 mL) of liquor.

  • Chronic use of supplements (vitamins, minerals or flavonoids)

  • Body mass index > 35 kg/m2

  • Chronic diseases: CHD, diabetes, etc.

  • Smokers (1 or more cigarette/day)

  • Dyslipidemia secondary to renal insufficiency, hypothyroidism or others

  • Any prior or current use of medications known to affect lipoprotein-lipid metabolism (e.g. statins, fibrates), endothelial function (hypotensive drugs). Use (ever) ofanticoagulant drugs (e.g. warfarin) because of possible detrimental interaction withthe consumption of cranberry juice. Current or recent (<2 weeks) use ofanti-inflammatory drugs Note: If for any reason, a subject would have to go an any ofthese drugs during the protocol, they would be automatically dropped from the study.

Study Design

Total Participants: 99
Study Start date:
February 01, 2006
Estimated Completion Date:
December 31, 2008

Connect with a study center

  • Institute of Nutraceuticals and Functional Foods

    Quebec, G1K 7P4
    Canada

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.